New Delhi: After World Health Organisation (WHO) alerted on four Indian-made cough syrups used for pediatric groups, the Central Drugs Standard Control Organisation (CDSCO) ordered a probe on Thursday.
According to sources close to ANI, “Urgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information.”
The report further added that “a robust National Regulatory Authority, WHO has been requested to share at the earliest with CDSCO the report on the establishment of causal relation to death with the medical products in question, photographs of Labels/ products, etc.”
Earlier on Wednesday, WHO issued an alert over four Indian-made cough syrups by Maiden Pharmaceuticals in India. WHO has also notified that the same cough and cold syrups could be linked to the deaths of 66 children in The Gambia.
A preliminary report suggests that Maiden Pharmaceutical Limited, based in Sonipat, is a manufacturer licensed by the State Drug Controller for the products under reference, and holds manufacturing permission for these products.
The company has manufactured and exported these products only to The Gambia so far. The report added that “tentative results received by WHO out of the 23 samples tested, four samples have been found to contain Diethylene Glycol/ Ethylene Glycol as indicated. It has also been informed by WHO that the certificate of analysis will be made available to WHO in near future and WHO will share it with India.”
(With Agency Inputs)
Click here for Latest News updates and viral videos on our AI-powered smart news
For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram